Articles tagged with Viruses
Researchers at Spanish National Research Council (CSIC) propose using viral vectors to introduce specific genes into crops, improving their traits such as drought tolerance and nutritional value. The approach is considered more efficient and sustainable than traditional breeding methods.
A new study by the UK Centre for Ecology & Hydrology predicts high-risk towns across Europe for dengue fever outbreaks, with southern France and northern Italy being most affected. The research uses advanced high-resolution modeling to provide daily risk assessments for each area.
Researchers at the University of Copenhagen have identified the protein complex that enables the hepatitis C virus to infect cells. This discovery is a significant step towards developing a vaccine against the disease, which causes chronic inflammation and 300,000 deaths annually worldwide. The study's results, published in Nature maga...
Scientists from Spirovant Sciences describe a novel adeno-associated virus (AAV) gene therapy called SP-101 that has been optimized for efficient human airway cell transduction. After single dose inhaled delivery, the vector showed consistent expression of a functional and regulated shortened human CFTR minigene.
Researchers have discovered a significant link between viruses and disease-causing nematodes, opening up new avenues for treatment. The study identified 91 RNA viruses in 28 species of parasitic nematodes, which may contribute to chronic debilitating conditions.
Researchers identified a genetic mutation that impairs virus replication in human cells, leading to asymptomatic infections. The same mutation enhances transmission in Aedes aegypti mosquitoes, allowing the virus to spread without triggering an outbreak.
A new Swedish registry study found that girls with mental illness or neurodevelopmental conditions have lower HPV vaccination coverage compared to their peers. The study involved over 115,000 girls and found significant differences in vaccination rates among those with psychiatric diagnoses or receiving psychotropic medications.
A five-year study led by Tulane University is investigating a new medication to treat trichomoniasis. The research compares secnidazole with metronidazole, finding that one-dose treatment could offer better options for the infection, which affects 156 million people annually.
A new study has reconstructed virus DNA from glacial ice cores, revealing nearly 1,700 viral species with adaptations that influenced their hosts' survival in extreme conditions. The findings suggest a connection between viruses and climate change, shedding light on the impact of global temperature shifts.
Researchers from POSTECH and KRICT created a 3D artificial lung using bioprinting technology, closely mimicking the human respiratory tract. This model allows for accurate testing of COVID-19 drugs and development of therapeutic treatments, potentially shortening the drug development process to under 5 years.
The research aims to develop a new method for detecting foodborne viruses like norovirus and hepatitis A in time to prevent or quickly respond to an outbreak. The technology uses magnetic liquids to concentrate viruses from large food samples into smaller volumes, streamlining the detection process.
Researchers at Auburn University are developing a new instrument to characterize respiratory aerosols, which can transport viruses over longer distances. The technique uses fluorescence to analyze particles sensitive to pH, viscosity, and phase state.
The study found that subtle shifts in the shape of viral spike proteins changed targetable host receptors, leading to the virus's decline as a human pathogen. Researchers also discovered that some strains could stick their spike proteins to multiple receptors, challenging previous assumptions about viral behavior.
A new drug has shown promise in clearing HIV from the brain by targeting infected cells and reducing viral load. The treatment, BLZ945, successfully cleared the virus from brain tissue, providing a potential new avenue for HIV treatment.
Researchers at George Mason University's Center for Infectious Disease Research have made a breakthrough in finding a functional cure for HIV. Using an HIV-like virus particle called HIV Rev-dependent lentiviral vector, the team was able to reduce viral reservoirs and boost the immune system to produce antiviral neutralizing antibodies.
Researchers from Rice University discovered that viruses achieve precise timing in cell lysis by balancing the buildup and breakdown of holin proteins. This balance ensures optimal cell bursting, essential for viral replication, despite underlying randomness in biological processes.
Research reveals native plants and non-native crops attract pests that spread diseases, causing harm to both plant populations. The studies also found viruses transmitted from crops to wild plants, which can have devastating effects on native ecosystems.
Researchers have discovered how a neutralizing antibody blocks measles virus infection by arresting the fusion process. The study's findings may also be relevant to other viruses with pandemic potential, such as Nipah and parainfluenza viruses.
Researchers used single-cell sequencing technology to study immune responses in healthy adult volunteers exposed to SARS-CoV-2. They discovered unique immune responses associated with resisting sustained viral infection and disease, including activation of specialized mucosal immune cells and a reduction in inflammatory white blood cells.
Studies found that wood reduces viral infectivity on its surface, with pine and spruce showing the fastest onset of antiviral activity. The researchers concluded that wood's chemical composition is responsible for its antiviral functionality.
The team created finely detailed images of the viral RNA and replication structures, revealing spherical shapes around the nucleus of infected cells. The images provide insight into how the virus evades cell defenses and could lead to new therapeutic targets for drug development.
Researchers at the University of Toronto discovered a new RNA virus, Apocryptovirus odysseus, associated with severe inflammation in humans infected with Toxoplasma gondii. The virus is found in two hypervirulent strains of the parasite, exacerbating toxoplasmosis disease and triggering an immune response.
Researchers discovered that children with the worst outcomes had significantly fewer microbial species overall, but marked populations of Staphylococcus bacteria and viruses. The study used metagenomic next-generation sequencing to analyze lung fluid samples from 229 pediatric patients, revealing links between microbiome composition an...
A cluster randomized trial found that at-school HPV vaccination significantly increased vaccination coverage, but training general practitioners and education had limited impact. The study aimed to assess the effectiveness of a school- and primary care-based HPV vaccination intervention.
A new approach to fighting Epstein-Barr virus-related diseases has been discovered by University of Basel researchers. By inhibiting a specific metabolic pathway in infected cells, the risk of downstream disease can be diminished.
Researchers at the University of Leeds identified a surge in rare autoimmune cases linked to MDA5 autoimmunity, affecting mainly white men and women. The condition, characterized by skin rashes, pneumonia, and interstitial lung disease, has proven fatal in some cases.
Researchers at Harvard University have identified a specific cell type in the mouse embryonic brain that responds to an immune response in the mother, altering gene regulation and persisting in juvenile mice. This study provides new insights into how maternal immune responses might influence brain development in embryos, potentially sh...
The Connecticut Veterinary Medical Diagnostic Laboratory sequenced a case of rabies from a black bear found in the state. The lab compared the genome with existing rabies sequences to identify a rare viral strain, closely resembling one from a raccoon in New England.
Public health authorities in nearly all US states and territories have the ability to monitor and test persons exposed to H5N1 virus. Despite this, jurisdictions vary in their preparedness plans, antiviral use recommendations, and potential vaccine deployment among first responders.
Researchers discovered a compound that inhibits cathepsin types, preventing hepatitis E virus infection in human liver cells. The study provides hope for an effective treatment against this deadly disease, which kills approximately 70,000 people annually.
F. William Studier, a senior biophysicist at Brookhaven National Laboratory, has won the 2024 Merkin Prize in Biomedical Technology for his T7 expression technology, enabling large-scale production of RNA and proteins for biomedical research and pharmaceuticals. His work has saved millions of lives with COVID-19 mRNA vaccines.
Researchers developed a synthetic biomarker technology that can differentiate between prior Zika and dengue virus infections. The technology, using epitope surrogates, correctly identified people previously infected with Zika virus 85.3% of the time.
The 5-year TAF treatment efficacy was high and similar to that of 3-year TDF followed by 2-year TAF in Chinese chronic hepatitis B patients. Favorable effects on bone and renal parameters were sustained with TAF treatment alone and were observed following the switch from TDF to TAF.
Studies found a negative relationship between HBV replication and liver inflammation in HBeAg-positive patients with high viral DNA levels, which shifted to positive relationships for those with low DNA levels or HBeAg-negative status. This interaction suggests a complex relationship between viral replication and liver damage progression.
A new study reveals that honey bees are exposed to an average of 23 stressors at once, creating 307 interactions that impact bee health. The researchers found that social media influencers – viruses and pesticides – have a significant impact on the architecture of the complex network.
Researchers at UC Riverside demonstrate a new vaccine strategy targeting a common viral genome part, eliminating the need for annual booster shots. The vaccine uses small RNA molecules to boost the immune system, making it safe for babies and those with weakened immunity.
A new lab-on-a-chip system combines optofluidics and nanopores to rapidly test for SARS-CoV-2 and Zika viruses with high accuracy. The tool, developed by UC Santa Cruz researchers, can detect viruses at extremely low concentrations and outperform PCR tests in some cases.
Researchers developed molecular probes that react to the unique pH environment of certain mosquito larvae, which could be used to create highly specific insecticides. These probes bind to proteins in the gut and can be detected using fluorescence, minimizing side effects.
Researchers have discovered a virus that infects the fungus Batrachochytrium dendrobatidis, which causes heart failure in frogs and toads. The virus could be engineered to control the fungal disease and potentially save amphibian species.
A second-generation melanoma vaccine has shown improved survival rates for male patients compared to female patients, particularly those who are younger and have earlier-stage cancer. The vaccine targets helper T cells to recognize melanoma proteins, leading to boosted patient survival and reduced cancer reoccurrences.
A recent study published in Phytobiomes Journal found that non-native crop viruses are infecting and harming wild desert plants. Infection rates with the virus CABYV reached as high as 88% in some populations, causing visible impacts on plant growth and root health.
Researchers developed a new triplex real-time PCR test to detect the emerging Powassan virus in deer ticks, improving sensitivity and accuracy. The method reduced false negative results, providing assurance that negative test results are true negatives.
A new virus-killing surface made of silicon nanospikes has shown 96% effectiveness against the hPIV-3 virus, damaging its structure and membranes. The surface can be incorporated into devices and surfaces to prevent viral spread and reduce disinfectant use.
Researchers found that early antibiotic treatment accelerated recovery in COVID-19 patients. The study used a combination of antibiotics, including amoxicillin and rifaximin, within the first three days of infection. This treatment significantly reduced the risk of long-term COVID symptoms.
A randomized clinical trial of 345 patients with mild-to-moderate COVID-19 found that viral load and symptom rebound were common after a standard 5-day course of antiviral treatment. Prolonging treatment duration may help reduce COVID-19 rebound
Researchers discover that certain bacteria can evade the immune system by circumventing antibody coating, leading to severe inflammation. The study identifies IgG2 as a key player in this process, providing potential biomarkers and targets for new treatments.
A computational model of the more than 26 million atoms in a DNA-packed viral capsid has expanded our understanding of virus structure and DNA dynamics. The study found that the DNA formed switchback loops as it was pushed into the capsid, similar to how DNA is organized in eukaryotic cells.
A novel antibody constant region variant (REW) extends plasma half-life and improves biodistribution, allowing for both invasive and non-invasive delivery. The REW technology also enhances the complement system, providing enhanced ability to kill cancer cells and bacteria.
A study by Texas A&M University found that only 9% of older Americans had been vaccinated against RSV prior to this fall and winter. The study also revealed that men were more likely to be vaccinated than women, and those who were vaccinated had higher levels of concern about the disease.
Researchers found that faulty mtDNA replication causes mitochondria to leak genetic material, triggering an immune response and leading to disease. By targeting this process, doctors may develop therapies to prevent harmful inflammation.
Researchers found that KSHV manipulates human enzymes CDK6 and CAD to reshape cellular metabolism and proliferation, leading to tumor formation. Inhibiting this process with existing FDA-approved breast cancer drugs reduced viral replication and shrunk tumors in preclinical models.
Researchers at Martin-Luther-Universität Halle-Wittenberg developed novel RNA- or DNA-based substances that reliably fight off viral infections in plants. The new approach uses antisense oligonucleotides to target specific viral RNA molecules, achieving an impressive up to 90% success rate against a common virus.
Researchers found that microbial viruses carry special genetic elements for controlling methane processes, called auxiliary metabolic genes (AMGs). The study suggests that viral contributions to methane cycling are underestimated and deserve more attention.
A UC Riverside-led study has devised a way to make large quantities of the Membrane protein, which plays a crucial role in how SARS-CoV-2 acquires its spherical structure. The researchers found that when the M protein interacts with the membrane, it coaxes the membrane to curve, leading to the virus's characteristic shape.
A recent study by Pusan National University scientists discovered the crucial role of PKM gene and EPHA2 pathway in HNSCC development. The research highlights the importance of HPV infection status in shaping the tumor microenvironment, enabling precision medicine for targeted treatment.
Researchers found that e-liquids containing propylene glycol and vegetable glycerin enhance COVID-19 infection, while those with benzoic acid prevent it. Vapers are advised to quit or switch to e-liquids with acidic pH for better protection.
Researchers at ISTA have discovered the composition of poxviral cores, a key factor in their infectivity. The study's findings could lead to the development of new therapeutics targeting the viral core.
A University of Edinburgh-led research team traced the lineage of 743 RNA virus species to track their evolution and identify those most likely to emerge and spread rapidly in humans. The findings show that viruses that can spread within human populations typically evolve separately from strictly zoonotic viruses.
Researchers have discovered a novel RNA viral genome from thermoacidophilic microbes in hot springs, revealing a previously overlooked third RNA virus kingdom. The discovery sheds light on the diversity and evolution of RNA viruses and their potential roles in high-temperature environments.
A new surface technology has been developed that reduces viruses' infection ability by 96% using mechanical methods. The surface, made of silicon with tiny spikes, damages the structure of viruses when they come into contact with it.